Max Robotics — Global Service Robot Directory + US Certification

About

Ryan P. Merkow is a surgical oncologist and health services researcher whose work centers on improving the quality and outcomes of complex gastrointestinal cancer surgery. His major contributions lie in defining evidence-based quality metrics for esophageal and pancreatic cancer care, with a particular focus on the role of lymphadenectomy and the comparative effectiveness of minimally invasive versus open surgical approaches. Notably, his 2020 study on adequate lymphadenectomy as a quality measure in esophageal cancer (23 citations) has helped shape surgical standards by demonstrating how treatment approach influences nodal harvest and, ultimately, patient prognosis. Merkow is also at the forefront of evaluating the global diffusion of robotic surgery, examining the financial, infrastructural, and educational barriers that limit its adoption in resource-constrained settings—a critical issue for equitable surgical innovation. His comparative analysis of open versus minimally invasive pancreatoduodenectomies (2024) further underscores his commitment to evidence-based surgical decision-making. Through these contributions, Merkow has established himself as a key voice in surgical quality improvement and the responsible integration of new technologies into cancer care.